Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience
Dr. Vince Clinical Research (DVCR), a world-class contract research organization (CRO) specializing in early phase clinical trials, today announced the addition of two key leadership roles to its Phase I research team.
Michelle Neaderhiser joins the organization as the Director of Study Management, leveraging her 25+ years of experience in clinical research. She will oversee the study management team at DVCR’s clinical pharmacology unit to ensure trials are completed per protocol and to the sponsor’s expectations.
“I am excited to join the Dr. Vince Clinical Research team and utilize my expertise in the execution of clinical studies by delivering data quality above industry standards,” Neaderhiser said.
Chris Hardage also joins DVCR with 25+ years of clinical research experience as the Director of Clinical Trial Services.
“I look forward to collaborating with my fellow colleagues on the leadership team as we develop solution-focused methods that result in the delivery of smarter, faster data,” Hardage said.
“With these additions we have positioned ourselves as one of the most experienced early phase clinical research companies in the country, allowing us to provide smarter, faster data to our biopharmaceutical clients,” said CEO and Medical Director Dr. Brad Vince. “Our organization continues to make significant investments in our employees and leadership team.”
About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a world-class CRO (Contract Research Organization) with a custom-built, green-designed headquarters and research complex encompassing three buildings in Overland Park, KS. DVCR’s complex includes a 90-bed clinical pharmacology unit featuring a combination of luxurious and private research suites and a GMP compliant pharmacy with positive and negative pressure compounding rooms. DVCR specializes in conducting clinical trials for both healthy normal volunteers and patient populations in a wide variety of early phase trials. By leveraging both technology and one of the country’s most experienced leadership teams, DVCR provides Smarter, Faster Data™ to their biopharmaceutical clients.